Peptide Synthesis Market to Surpass US$ 546.3 Million by 2027 - Coherent Market Insights

Global Peptide Synthesis Market, by Product (Reagents & Consumables and Equipment (Peptide Synthesizers, Lyophilizers, and Chromatography Equipment)), by Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), by Application (Therapeutics (Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Infectious Diseases, and Others), Diagnosis, and Research), by End User (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO), and Academic & Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 348.9 million in 2020 and is expected to exhibit a CAGR of 6.6% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

Research & development by market players to augment the market growth

Major players in the market are focused on research and development of novel products for peptide synthesis, which is expected to boost the market growth. For instance, in January 2018, CEM Corporation launched Liberty PRIME, an automated microwave peptide synthesizer. This product is the efficient peptide synthesizer, which utilizes a methodology- solid phase peptide synthesis.

Global Peptide Synthesis Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 68.16 million infected individuals worldwide, as of December 10, 2020.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channel, and by its financial impact on firms and financial markets. Due to lockdowns, several countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of such devices from one place to another.

Moreover, a disease outbreak/pandemic of COVID-19, researchers are in a prime position to identify and develop peptide-based therapies for the diagnosis of COVID-19, which could be more rapidly and cost-effectively advanced into a clinical setting. However, drawback of natural peptide drugs include proteolytic instability and peptidomimetics can help to overcome this limitation.

Browse 40 Market Data Tables and 35 Figures spread through 200 Pages and in-depth TOC on “Peptide Synthesis Market – by Product (Reagents & Consumables and Equipment (Peptide Synthesizers, Lyophilizers, and Chromatography Equipment)), by Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), by Application (Therapeutics (Metabolic Disorders, Cardiovascular Disorders, Respiratory Disorders, Infectious Diseases, and Others), Diagnosis, and Research), by End User (Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization (CDMO)/Contract Research Organization (CRO), and Academic & Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2027”

To know the latest trends and insights prevalent in the global peptide synthesis market, click the link below:

https://www.coherentmarketinsights.com/market-insight/peptide-synthesis-market-4336

Key players in the market are focusing on novel products approvals and launches for peptide synthesis. For instance, in January 2019, SP Scientific, a leading manufacturer of freeze dryers/ lyophilizers and others, launched LyoS 2.0, a line-of-sight enabled lyophilizer control system. This product is able to control peptide synthesis platforms from development to production units, making cycle transfer and scale-up that much simpler.

Key Takeaways of the Global Peptide Synthesis Market:

• The global peptide synthesis market is expected to exhibit a CAGR of 6.6% during the forecast period, owing to rising incidence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. For instance, according to the facts and figures published by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) in July 2019, reports that 65 million people suffer from chronic obstructive pulmonary disease (COPD) each year globally, which makes it the third leading cause of death worldwide.
• Among technology, solid phase segment held a dominant position in the peptide synthesis market in 2019, owing to its ability to be used in large scale production of peptides for industrial purposes
• Among application, metabolic disorders sub segment held a dominant position in the peptide synthesis market in 2019, owing to rising cases of metabolic disorders such as diabetes. For instance, according to the facts and figures published by the Global Initiative for American Diabetes Association (ADA) in July 2018, reports that 34.2 million Americans, or 10.5% of the population had diabetes.
• Among end user, pharmaceutical and biotechnology companies segment held a dominant position in the peptide synthesis market in 2019, owing to increasing usage of peptides in the therapeutic industry.
• Key players operating in the global peptide synthesis market include GenScript Biotech Corporation, Merck KGaA, ThermoFisher Scientific Inc., Syngene, Lonza, Novo Nordisk A/S, Bachem Holding AG, Gyros Protein Technologies, Creative Diagnostics, CEM Corporation, PuroSynth, AAPPTec, and Biotage AB among others.